Alprazolam in Panic Disorder and Agoraphobia: Results From a Multicenter Trial: III. Discontinuation Effects

Archives of General Psychiatry

Volumn 45, Issue 5, 1988, Pages 429-436

  Pecknold, John C ^a   Swinson, Richard P ^b   Kuch, Klaus ^c   Lewis, Carl P ^d  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c TORONTO GENERAL HOSPITAL   (Canada)

^d PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM;

ADULT; AGORAPHOBIA; ANXIETY; HUMAN; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; PANIC; PSYCHOLOGICAL ASPECT; RELAPSE; WITHDRAWAL SYNDROME;

ADULT; ALPRAZOLAM; ANXIETY DISORDERS; CLINICAL TRIALS; DRUG ADMINISTRATION SCHEDULE; FEAR; FEMALE; HUMAN; MALE; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PANIC; PERSONALITY INVENTORY; PLACEBOS; PSYCHIATRIC STATUS RATING SCALES; RECURRENCE; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 0023886672     PISSN: 0003990X     EISSN: 15383636     Source Type: Journal    
DOI: 10.1001/archpsyc.1988.01800290043006     Document Type: Article

References (96)

1. Robins LN, Helzer JG, Weissman MM, Orvaschel H, Gruenberg E, Burke JD Jr, Regier DA: Lifetime prevalence of specific psychiatric disorders in three sites. Arch Gen Psychiatry 1984;41:949-958.
2. Sheehan DV: The treatment of panic attacks with agoraphobia, with alprazolam and ibuprofen: A controlled study, abstracted. Abstracts of the Scientific Proceedings of the 137th Annual Meeting of the American Psychiatric Association, Toronto, May 11, 1982.
3. Sheehan DV: The relative efficacy of phenelzine, imipramine, alprazolam and placebo in the treatment of panic attacks and agoraphobia. Read before the Meeting on Biology of Panic Disorders, Boston, Nov 5, 1983.
4. Sheehan DV, Claycomb JB, Surman OS: Comparison of phenelzine, imipramine, alprazolam, and placebo in the treatment of panic attacks and agoraphobia, abstracted. Abstracts of the Scientific Proceedings of the 137th Annual Meeting of the American Psychiatric Association, Los Angeles, May 8, 1984.
5. Alexander DE, Alexander DD: Alprazolam treatment for panic disorders. J Clin Psychiatry 1986;47:301-304.
6. Shehi M, Patterson W: Treatment of panic with alprazolam and propranolol. Am J Psychiatry 1984;141:900-901.
7. Charney DS, Woods SW, Goodman WK, Rifkin A, Kimch M, Aiken B, Quadrino LM, Heninger GR: Drug treatment of panic disorder: The comparative efficacy of imipramine, alprazolam and trazodone. J Clin Psychiatry 1986;47:580-586.
8. Ballenger JC, Burrows GD, DuPont RL Jr, Lesser IM, Noyes R Jr, Pecknold JC, Rifkin A, Swinson RP: Alprazolam in panic disorder and agoraphobia: Results from a multicenter trial: I. Efficacy in short-term treatment. Arch Gen Psychiatry 1988;45:413-422.
9. Hollister LE, Motzenbecker FP, Degan RO: Withdrawal reactions from chlordiazepoxide (Librium). Psychopharmacologia 1961;2:63-68.
10. Covi L, Lipman RS, Pattison JH, Derogatis LR, Uhlenhuth EH: Length of treatment with anxiolytic sedatives and response to their sudden withdrawal. Acta Psychiatr Scand 1973;49:51-64.
11. Bant W: Diazepam withdrawal symptoms. Br Med J 1975;4:285.
12. Vyas I, Carney MW: Diazepam withdrawal fits. Br Med J 1975;4:44.
13. Floyd JB, Murphy CM: Hallucinations following withdrawal of Valium. J Ky Med Assoc 1976;74:549-550.
14. Rifkin A, Quitkin F, Klein DF: Withdrawal from diazepam. JAMA 1976;238:306.
15. Ecker A: Withdrawal convulsions or stress convulsions. JAMA 1977;237:765.
16. Dysken MW, Chan CH: Diazepam withdrawal psychosis: A case report. Am J Psychiatry 1977;134:573.
17. Minter R, Murray GB: Diazepam withdrawal: A current problem in recognition. J Fam Pract 1978;7:1233-1235.
18. De Bard ML: Diazepam withdrawal syndrome: A case with psychosis, seizure and coma. Am J Psychiatry 1979;136:104-105.
19. Winoker A, Rickels K, Greenblatt DJ, Snyder PJ, Schatz NJ: Withdrawal reaction from long-term low dosage administration of diazepam: A double-blind placebo controlled case study. Arch Gen Psychiatry 1980;37:101-105.
20. Abernathy DR, Greenblatt DJ, Shader RI: Treatment of diazepam withdrawal syndrome with propranolol. Ann Intern Med 1981;94:354-355.
21. Winoker A, Rickesz K: Withdrawal and pseudowithdrawal from diazepam therapy. J Clin Psychiatry 1981;42:442-444.
22. Robinson GM, Sellers EM: Diazepam withdrawal seizures. Can Med Assoc J 1982;126:944-945.
23. Stewart RB, Salem RB, Springer PK: A case report of lorazepam withdrawal. Am J Psychiatry 1980;137:1113-1114.
24. Howe JG: Lorazepam withdrawal seizures. Br Med J 1980;1:1163-1164.
25. Barton DF: More on lorazepam withdrawal. Drug Intell Clin Pharm 1981;15:135.
26. Petursson H, Lader MH: Benzodiazepine dependence. Br J Addict 1981;76:143-145.
27. Misra PC: Nitrazepam (Mogadon) dependence. Br J Psychiatry 1975;126:81-82.
28. Adams K, Adamson L, Brezinova V, Hunter WM, Oswald I: Nitrazepam: Lastingly effective but trouble on withdrawal. Br MedJ 1976;1:1158-1160.
29. Selig JW: A possible oxazepam abstinence syndrome. JAMA 1966;198:279-280.
30. Hanna SM: A case of oxazepam (Serenid-D) dependence. Br J Psychiatry 1972;120:443-451.
31. Mendelson G: Withdrawal reaction after oxazepam. Lancet 1978;1:565.
32. LeBellec M, Bismuth C, Lagier G, Dally S: Syndrome de sevrage severe apres arret des benzodiazepines. Therapie 1980;35:113-118.
33. Khan A, Joyce P, Jones AV: Benzodiazepine withdrawal syndromes. NZ Med J 1980;92:94-96.
34. Preskorn E, Denner J: Benzodiazepines and withdrawal psychosis: Report of three cases. JAMA 1977;237:36-38.
35. Pecknold JC, McClure DJ, Fleuri D, Chang H: Benzodiazepine withdrawal effects. Prog Neuropsychopharmacol Biol Psychiatry 1982;6:517-522.
36. Breier A, Charney DS, Nelson CJ: Seizures induced by abrupt discontinuation of alprazolam. Am J Psychiatry 1984;141:1606-1607.
37. Levy AB: Delirium and seizures due to abrupt alprazolam withdrawal: Case report. J Clin Psychiatry 1984;45:38-39.
38. Noyes R Jr, Clancy J, Coryell WH, Crowe RR, Chaudhry DR, Domingo DV: A withdrawal syndrome after abrupt discontinuation of alprazolam. Am J Psychiatry 1985;142:114-116.
39. Zipursky RB, Baker RW, Zimmer B: Alprazolam withdrawal delirium unresponsive to diazepam: Case report. J Clin Psychiatry 1985;46:344-345.
40. Noyes R Jr, Perry PJ, Crowe RR, Coryell WH, Clancy J, Yamada T, Gabel J: Seizures following the withdrawal of alprazolam. J Nerv Ment Dis 1986;174:50-52.
41. Vital-Herne J, Brenner R, Lesser M: Another case of alprazolam withdrawal syndrome. Am J Psychiatry 1985;142:1515.
42. Kantor SJ: A difficult alprazolam withdrawal. J Clin Psychopharmacol 1986;6:124-125.
43. Fernando L, Sagi E: Alprazolam withdrawal syndrome. Can J Psychiatry 1986;31:488.
44. Slak S: Alprazolam withdrawal insomnia. Psychol Rep 1986;58:343-346.
45. Swinson RP, Pecknold JC, Kirby ME: Benzodiazepine dependence. J Affective Disord 1987;13:109-118.
46. Marks J: The Benzodiazepines, Use, Overuse, Misuse, Abuse. Lancaster, England, MTP Press Ltd, 1978.
47. Browne JL, Hauge KJ: A review of alprazolam withdrawal. Drug lntell Clin Pharm 1986;20:837-840.
48. Rementeria JL, Blatt K: Withdrawal symptoms in neonates from intrauterine exposure to diazepam. J Pediatr 1977;90:123-126.
49. Athianarayanan P, Pierog SH, Sarvesh KN, Glass L: Chlordiazepoxide withdrawal in the neonate. Am J Obstet Gynecol 1976;124:212-231.
50. Tyrer R, Rutherford D, Huggett T: Benzodiazepine withdrawal symptoms and propranolol. Lancet 1981;1:520-522.
51. Hallstrom C, Lader MH: Benzodiazepine withdrawal phenomena. Int Pharmacopsychiatry 1981;16:235-244.
52. Petursson H, Lader MH: Withdrawal from long-term benzodiazepine treatment. Br Med J 1981;283:643-645.
53. Rickels K, Cose G, Downing RW: Issues in longterm treatment with diazepam. Psychopharmacol Bull 1982;18:38-41.
54. Langhren TP, Balley Y, Greenblatt DJ: A controlled trial of diazepam withdrawal in chronically anxious outpatients. Acta Psychiatr Scand 1982;65:171-179.
55. Lapierre YD, Tremblay A, Gagnon A, Montpremier P, Berliss H, Oyewumi LK: A therapeutic and discontinuation study of clobazam and diazepam in anxiety neurosis. J Clin Psychiatry 1982;43:372-374.
56. Fontaine R, Chouinard G, Annable L: Rebound anxiety in anxious patients after abrupt withdrawal of benzodiazepine treatment. Am J Psychiatry 1984;141:848-852.
57. Tyrer P, Owen R, Dawling S: Gradual withdrawal of diazepam after long-term therapy. Lancet 1983;1:1402-1406.
58. Mellman TA, Uhde TW: Withdrawal syndrome with gradual tapering of alprazolam. Am J Psychiatry 1986;143:1464-1466.
59. Fyer AJ, Liebowitz MR, Gorman JM, Campeas R, Levin A, Davies SO, Goetz D, Klein D: Discontinuation of alprazolam treatment in panic patients. Am J Psychiatry 1987;144:303-308.
60. Pecknold JC, Swinson RP: Taper withdrawal studies with alprazolam in patients with panic disorder and agoraphobia. Psychopharmacol Bull 1986;22:173-176.
61. Lapierre YD: Benzodiazepine withdrawal. Can J Psychiatry 1981;26:93-95.
62. Breier A, Charney DS, Heninger GR: Agoraphobia with panic attacks: Development diagnostic stability and course of Illness. Arch Gen Psychiatry 1986;43:1029-1036.
63. Marks IM: Agoraphobic syndrome (phobic anxiety state). Arch Gen Psychiatry 1970;23:538-553.
64. Errera P, Coleman JV: A long-term follow-up study of neurotic phobic patients in a psychiatric clinic. J Nerv Ment Dis 1963;136:267-271.
65. Roberts AH; Housebound housewives: A follow-up study of a phobic anxiety state. Br J Psychiatry 1964;110:191-197.
66. Coryell W, Noyes R, Clancy J: Panic disorder and primary unipolar depression: A comparison of background and outcome. J Affective Disord 1983;5:311-317.
67. Wheeler EO, White PD, Reed EW, Cohen ME: Neurocirculatory as- thenia: A 20 year follow-up study of 173 patients. JAMA 1953;142:878-889.
68. Thorpe GL, Burns LE: The Agoraphobic Syndrome. New York, John Wiley & Sons Inc, 1983.
69. Burns LE, Thorpe GL: The epidemiology of fears and phobias. J Int Med Res 1977;5:1-7.
70. Kales A, Scharf MB, Kales JD: Rebound insomnia: A new clinical syndrome. Science 1978;201:1039-1041.
71. Kales A, Scharf MB, Kales JD, Soldatos CR: Rebound insomnia: A potential hazard following withdrawal of certain benzodiazepines. JAMA 1979;241:1692-1695.
72. Allen S, Oswald I: Anxiety and sleep after fosazepam. Br J Clin Pharmacol 1976;3:165-168.
73. Lader M: Benzodiazepine withdrawal states, in Trimble MR (ed): Benzodiazepines Divided. New York, John Wiley & Sons Inc, 1983, pp 17-31.
74. Owen RT, Tyrer P: Benzodiazepine dependence: A review of the evidence. Drugs 1983;25:385-398.
75. Mellor CS, Jain VK: Diazepam withdrawal syndrome: Its prolonged and changing nature. Can Med Assoc J 1982;127:1093-1096.
76. Klerman GL Coleman JH, Purpura RP: The design and conduct of the Upjohn Cross-National Collaborative Panic Study. Psychopharmacol Bull 1985;22:59-64.
77. Spitzer RL, Williams BW: Structured Clinical Interview for DSMIII. New York, Biometrics Research Department, New York State Psychiatric Institute, 1982.
78. Sheehan DV, Coleman JH, Greenblatt DJ, Jones KJ, Levine PH, Orsulak PJ, Peterson M, Schildkraut JJ, Uzogara E, Watkins D: Some biochemical correlates of panic attacks with agoraphobia and their response to a new treatment. J Clin Psychopharmacol 1984;4:66-75.
79. Hamilton M: Diagnosis and ratings of anxiety. Br J Psychiatry 1969;3:76-79.
80. Marks IM, Mathews AM: Brief standard self-rating for phobic patients. Behav Res Ther 1979;17:263-267.
81. Merz WA, Ballmer V: Symptoms of the barbiturate/benzodiazepine withdrawal syndrome in healthy volunteers, abstracted. Abstracts of the Scientific Proceedings of the 13th Collegium Internationale Neuropsychopharmacologium Congress, Jerusalem, June 20-25, 1982.
82. Merz WA: Standardized assessment of the symptoms of the benzodiazepine withdrawal syndrome prior to, during and after treatment of anxiety with a benzodiazepine by means of a novel self-rating scale, abstracted. Abstracts of the Scientific Proceedings of the 13th Collegium Internationale Neuropsychopharmacologium Congress, Jerusalem, June 20-25, 1982.
83. Busto U, Sellers EM, Naranjo CA, Cappell H, Sancez-Craig M, Sykora K: Withdrawal reaction after long-term therapeutic use of benzodiazepines. N Engl J Med 1986;315:854-859.
84. Charney DS, Heninger GR: Noradrenergic function and the mechanism of action of antianxiety treatment. Arch Gen Psychiatry 1985;42:473-481.
85. Eriksson E, Carlsson H, Nilsson C, Soderpach B: Does alprazolam, in contrast to diazepam, activate alpha-2-adrenoceptors involved in the regulation of rat growth hormone secretion? Life Sci 1986;38:1491-1498.
86. Eriksson E: Brain neurotransmission in panic disorder. Acta Psychiatr Scand 1987;76(suppl 335):31-37.
87. Rastogi RB, Lapierre YD, Singhal RL: Synaptosomal uptake of norepinephrine and 5-hydroxytryptamine and synthesis of catecholamines during benzodiazepine treatment. Can J Physiol Pharmacol 1978;56:777-784.
88. Rastogi RB, Lapierre YD, Singhal RL: Evidence for the role of norepinephrine and dopamine in rebound phenomenon seen during withdrawal after repeated exposure to benzodiazepines. J Psychiatr Res 1976;13:65-75.
89. Agarwal RA, Lapierre YD, Rastogi RB, Singhal RL: Alterations in brain 5-hydroxytryptamines metabolism during the ‘withdrawal’ phase after chronic treatment with diazepam and bromazepam. Br J Pharmacol 1977;60:3-9.
90. Brown IR: Molecular Approaches to Neurobiology. Orlando, Fla, Academic Press, Inc, 1982.
91. Cowen PJ, Nutt DJ: Abstinence symptoms after withdrawal of tranquilizing drugs: Is there a common neurochemical mechanism? Lancet 1982;2:360-362.
92. Petursson H, Bond DA, Smith B, Lader MH: Monoamine metabolism during chronic benzodiazepine treatment and withdrawal. Biol Psychiatry 1983;18:207-213.
93. Charney DS, Woods SW, Goodman WK, Heninger GR: Neurobiological mechanisms of panic anxiety: Biochemical and behavioral correlates of yohimbine-induced panic attacks. Am J Psychiatry 1987;144:1030-1036.
94. Solyom C, Solyom L, Lapierre Y, Pecknold JC, Morton L: Phenelzine and exposure in the treatment of phobias. Biol Psychiatry 1981;16:239-247.
95. Zitrin CM, Klein DF, Woerner MG: Treatment of agoraphobia with group exposure in vivo and imipramine. Arch Gen Psychiatry 1980;37:63-72.
96. Zitrin CM, Klein DF, Woerner MG, Ross DC: Treatment of phobias: I. Comparison of imipramine hydrochloride and placebo. Arch Gen Psychiatry 1983;40:125-138.